evenfolioETF Details
JPMorgan·Health·JDOC · Nasdaq
JPMorgan Healthcare Leaders ETF (JDOC)
- Price
- $61.35
- —25 Sept 2026
- Assets
- $9.4M
- Total net assets
- Expense ratio
- 0.65%
- Category 1.00%
- Yield
- 0.82%
- Trailing distributions
- 1Y return
- 22.8%-13.2%
- Category 36.0%
- 3Y CAGR
- —
- Category 16.5%
- 5Y CAGR
- —
- Category 2.9%
Loading NAV history…
JPMorgan Healthcare Leaders ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | -4.2% | +1.4% | +13.4% | +6.0% | +22.8% | — | — | — | +10.6% |
| Health average | -3.2% | 5.9% | 25.6% | 16.1% | 36.0% | 16.5% | 2.9% | 9.1% | 11.4% |
| Difference | -1.0% | -4.5% | -12.3% | -10.1% | -13.2% | — | — | — | -0.8% |
Holdings
The 10 largest positions make up 46.5% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| ABBV | AbbVie Inc | 7.94% |
| LLY | Eli Lilly and Co | 7.58% |
| MRK | Merck & Co Inc | 5.31% |
| JNJ | Johnson & Johnson | 4.85% |
| TMO | Thermo Fisher Scientific Inc | 4.11% |
| UNH | UnitedHealth Group Inc | 3.63% |
| BMY | Bristol-Myers Squibb Co | 3.55% |
| AZN.L | AstraZeneca PLC | 3.46% |
| ABT | Abbott Laboratories | 3.15% |
| NOVO-B.CO | Novo Nordisk AS Class B | 2.92% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- 29.0
- P/B
- 4.5
- P/S
- 1.7
- P/CF
- 16.8
Sector allocation
Share of the equity the fund holds.
- Health care100.0%
Asset mix
- Stocks99.8%
- Cash0.3%
ETF details
- Issuer
- JPMorgan
- Category
- Equity · Health
- Ticker
- JDOC
- Exchange
- Nasdaq
- Inception
- 1 Nov 2023 (2.9 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.65% (category 1.00%)
- Holdings turnover
- 92% (category 51%)
- Distribution yield
- 0.82%
- Beta, 3 years
- 0.00
- Total net assets
- $9.4M
Prices and returns as of 25 Sept 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- IBRN · iShares Neuroscience and Healthcare ETFiShares · $7.8M · ER 0.47%
- HLTH · Tema Healthcare AI ETFTema ETFs · $7.7M
- THNR · Amplify Weight Loss Drug & Treatment ETFAmplify ETFs · $5.3M · ER 0.59%
- EKG · First Trust Nasdaq Lux Digital Health Solutions ETFFirst Trust · $4.4M · ER 0.65%
- NVOH · Novo Nordisk A/S (B Shares) ADRhedgedADRH · $3.9M · ER 0.19%
- WDNA · WisdomTree BioRevolution FundWisdomTree · $3.5M · ER 0.45%5Y -0.9%